Liav Abraham

Stock Analyst at Citigroup

(0.88)
# 3,683
Out of 4,842 analysts
14
Total ratings
50%
Success rate
-11.86%
Average return

Stocks Rated by Liav Abraham

Teva Pharmaceutical Industries
Apr 11, 2019
Maintains: Buy
Price Target: $27$23
Current: $17.71
Upside: +29.87%
Abeona Therapeutics
Nov 13, 2018
Maintains: Buy
Price Target: $800$700
Current: $6.12
Upside: +11,337.91%
DBV Technologies
Oct 2, 2017
Maintains: Buy
Price Target: $430$570
Current: $9.29
Upside: +6,035.63%